CTLA-4 +49 A/G gene polymorphism in Croatian and Slovenian multiple sclerosis patients

International Journal of Immunogenetics

Volumn 38, Issue 5, 2011, Pages 419-426

  Čizmarević, N Starčević ^a   Gasparovic I ^b   Peterlin, B ^c   Sepcic J ^a   Rudolf, G ^c   Kapovic M ^a   Lavtar, P ^c   Ristic S ^a  

^a UNIVERSITY OF RIJEKA   (Croatia)

^b KBC RIJEKA   (Croatia)

^c UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; CROATIA; DISEASE COURSE; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; SLOVENIA;

ADULT; ALLELES; CROATIA; CTLA-4 ANTIGEN; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; SLOVENIA;

EID: 80052849859     PISSN: 17443121     EISSN: 1744313X     Source Type: Journal    
DOI: 10.1111/j.1744-313X.2011.01027.x     Document Type: Article

References (49)

1. Andreevskii, T.V., Sudomoina, M.A., Gusev, E.I., Boiko, A.N., Alekseenkov, A.D. & Favorova, O.O. (2002) [Polymorphism A/G in position +49 of CTLA4 exon 1 in multiple sclerosis in Russians]. Molekuliarnaia Biologiia, 36, 643.
2. Bagos, P.G., Karnaouri, A.C., Nikolopoulos, G.K. & Hamodrakas, S.J. (2007) No evidence for association of CTLA-4 gene polymorphisms with the risk of developing multiple sclerosis: a meta-analysis. Multiple Sclerosis, 13, 156.
3. Baranzini, S.E. (2011) Revealing the genetic basis of multiple sclerosis: are we there yet? Current Opinion in Genetics and Development, 21, 317.
4. Bilinska, M., Frydecka, I., Noga, L., Dobosz, T., Zoledziewska, M., Suwalska, K., Tutak, A. & Pokryszko-Dragan, A. (2004) Progression of multiple sclerosis is associated with exon 1 CTLA-4 gene polymorphism. Acta Neurologica Scandinavica, 110, 67.
5. Bocko, D., Bilinska, M., Dobosz, T., Zoledziewska, M., Suwalska, K., Tutak, A., Gruszka, E. & Frydecka, I. (2003) Lack of association between an exon 1 CTLA-4 gene polymorphism A(49)G and multiple sclerosis in a Polish population of the Lower Silesia region. Archivum Immunologiae et Therapiae Experimentalis (Warsz), 51, 201.
6. Bonetti, A., Reunanen, K., Finnila, S., Koivisto, K., Wikstrom, J., Sumelahti, M.L. et al. (2004) A two-stage study on multiple sclerosis susceptibility and chromosome 2q33. Genes and Immunity, 5, 142.
7. Borhani Haghighi, A., Ghahramani, S., Azarpira, N., Pourjafar, M. & Nikseresht, A.R. (2008) Cytotoxic T lymphocyte associated antigen-4 exon 1 A/G polymorphism in Iranian patients with multiple sclerosis. European Journal of Neurology, 15, 862.
8. Bush, W.S., Sawcer, S.J., de Jager, P.L., Oksenberg, J.R., McCauley, J.L., Pericak-Vance, M.A. & Haines, J.L. (2010) Evidence for polygenic susceptibility to multiple sclerosis--the shape of things to come. American Journal of Human Genetics, 86, 621.
9. De Jager, P.L., Jia, X., Wang, J., de Bakker, P.I., Ottoboni, L., Aggarwal, N.T. et al. (2009) Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nature Genetics, 41, 776.
10. Dincic, E., Zivkovic, M., Stankovic, A., Obradovic, D., Alavantic, D., Kostic, V. & Raicevic, R. (2006) Association of polymorphisms in CTLA-4, IL-1RA and IL-1beta genes with multiple sclerosis in Serbian population. Journal of Neuroimmunology, 177, 146.
11. Dyment, D.A., Steckley, J.L., Willer, C.J., Armstrong, H., Sadovnick, A.D., Risch, N. & Ebers, G.C. (2002) No evidence to support CTLA-4 as a susceptibility gene in MS families: the Canadian Collaborative Study. Journal of Neuroimmunology, 123, 193.
12. Dyment, D.A., Ebers, G.C. & Sadovnick, A.D. (2004) Genetics of multiple sclerosis. Lancet Neurology, 3, 104.
13. Einarsdottir, E., Soderstrom, I., Lofgren-Burstrom, A., Haraldsson, S., Nilsson-Ardnor, S., Penha-Goncalves, C. et al. (2003) The CTLA4 region as a general autoimmunity factor: an extended pedigree provides evidence for synergy with the HLA locus in the etiology of type 1 diabetes mellitus, Hashimoto's thyroiditis and Graves' disease. European Journal of Human Genetics, 11, 81.
14. Favorova, O.O., Favorov, A.V., Boiko, A.N., Andreewski, T.V., Sudomoina, M.A., Alekseenkov, A.D., Kulakova, O.G., Gusev, E.I., Parmigiani, G. & Ochs, M.F. (2006) Three allele combinations associated with multiple sclerosis. BMC Medical Genetics, 7, 63.
15. Fernandez-Mestre, M., Sanchez, K., Balbas, O., Gendzekhzadze, K., Ogando, V., Cabrera, M. & Layrisse, Z. (2009) Influence of CTLA-4 gene polymorphism in autoimmune and infectious diseases. Human Immunology, 70, 532.
16. Fukazawa, T., Yanagawa, T., Kikuchi, S., Yabe, I., Sasaki, H., Hamada, T., Miyasaka, K., Gomi, K. & Tashiro, K. (1999) CTLA-4 gene polymorphism may modulate disease in Japanese multiple sclerosis patients. Journal of the Neurological Sciences, 171, 49.
17. Fukazawa, T., Kikuchi, S., Miyagishi, R., Niino, M., Yabe, I., Hamada, T. & Sasaki, H. (2005) CTLA-4 gene polymorphism is not associated with conventional multiple sclerosis in Japanese. Journal of Neuroimmunology, 159, 225.
18. Gudjonsdottir, A.H., Nilsson, S., Naluai, A.T., Ek, J., Amundsen, S.S., Wahlstrom, J. & Ascher, H. (2009) Association between genotypes and phenotypes in coeliac disease. Journal of Pediatric Gastroenterology and Nutrition, 49, 165.
19. Hafler, D.A., Compston, A., Sawcer, S., Lander, E.S., Daly, M.J., De Jager, P.L. et al. (2007) Risk alleles for multiple sclerosis identified by a genomewide study. New England Journal of Medicine, 357, 851.
20. Han, S., Li, Y., Mao, Y. & Xie, Y. (2005) Meta-analysis of the association of CTLA-4 exon-1 +49A/G polymorphism with rheumatoid arthritis. Human Genetics, 118, 123.
21. Harbo, H.F., Celius, E.G., Vartdal, F. & Spurkland, A. (1999) CTLA4 promoter and exon 1 dimorphisms in multiple sclerosis. Tissue Antigens, 53, 106.
22. Heggarty, S., Suppiah, V., Silversides, J., O'Doherty, C., Droogan, A., McDonnell, G., Hawkins, S., Graham, C. & Vandenbroeck, K. (2007) CTLA4 gene polymorphisms and multiple sclerosis in Northern Ireland. Journal of Neuroimmunology, 187, 187.
23. Heidari, A., Noori Daloii, M.R., Keramatipour, M., Rashikinezhad, A., Sahmani, A.A. & Amirzargar, A.A. (2010) CTLA-4 Gene Polymorphisms (-318C/T, +49A/G, +6230A/G) in Iranian Patients with Multiple Sclerosis. Iran Journal of Allergy, Asthma, and Immunology, 9, 219.
24. Kantarci, O.H., Hebrink, D.D., Achenbach, S.J., Atkinson, E.J., Waliszewska, A., Buckle, G., McMurray, C.T., de Andrade, M., Hafler, D.A. & Weinshenker, B.G. (2003) CTLA4 is associated with susceptibility to multiple sclerosis. Journal of Neuroimmunology, 134, 133.
25. Karabon, L., Kosmaczewska, A., Bilinska, M., Pawlak, E., Ciszak, L., Jedynak, A. et al. (2009) The CTLA-4 gene polymorphisms are associated with CTLA-4 protein expression levels in multiple sclerosis patients and with susceptibility to disease. Immunology, 128, e787.
26. Kavvoura, F.K. & Ioannidis, J.P. (2005) CTLA-4 gene polymorphisms and susceptibility to type 1 diabetes mellitus: a HuGE Review and meta-analysis. American Journal of Epidemiology, 162, 3.
27. Lee, Y.H., Harley, J.B. & Nath, S.K. (2005) CTLA-4 polymorphisms and systemic lupus erythematosus (SLE): a meta-analysis. Human Genetics, 116, 361.
28. Ligers, A., Xu, C., Saarinen, S., Hillert, J. & Olerup, O. (1999) The CTLA-4 gene is associated with multiple sclerosis. Journal of Neuroimmunology, 97, 182.
29. Ligers, A., Teleshova, N., Masterman, T., Huang, W.X. & Hillert, J. (2001) CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms. Genes and Immunity, 2, 145.
30. Lorentzen, A.R., Celius, E.G., Ekstrom, P.O., Wiencke, K., Lie, B.A., Myhr, K.M. et al. (2005) Lack of association with the CD28/CTLA4/ICOS gene region among Norwegian multiple sclerosis patients. Journal of Neuroimmunology, 166, 197.
31. Lublin, F.D. & Reingold, S.C. (1996) Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology, 46, 907.
32. Malferrari, G., Stella, A., Monferini, E., Saltini, G., Proverbio, M.C., Grimaldi, L.M., Rossi-Bernardi, L. & Biunno, I. (2005) Ctla4 and multiple sclerosis in the Italian population. Experimental and Molecular Pathology, 78, 55.
33. Masterman, T., Ligers, A., Zhang, Z., Hellgren, D., Salter, H., Anvret, M. & Hillert, J. (2002) CTLA4 dimorphisms and the multiple sclerosis phenotype. Journal of Neuroimmunology, 131, 208.
34. Maurer, M., Loserth, S., Kolb-Maurer, A., Ponath, A., Wiese, S., Kruse, N. & Rieckmann, P. (2002a) A polymorphism in the human cytotoxic T-lymphocyte antigen 4 (CTLA4) gene (exon 1 +49) alters T-cell activation. Immunogenetics, 54, 1.
35. Maurer, M., Ponath, A., Kruse, N. & Rieckmann, P. (2002b) CTLA4 exon 1 dimorphism is associated with primary progressive multiple sclerosis. Journal of Neuroimmunology, 131, 213.
36. Oksenberg, J.R. & Baranzini, S.E. (2010) Multiple sclerosis genetics - is the glass half full, or half empty? Nature Reviews. Neurology, 6, 429.
37. Palacios, R., Comas, D., Elorza, J. & Villoslada, P. (2008) Genomic regulation of CTLA4 and multiple sclerosis. Journal of Neuroimmunology, 203, 108.
38. Pender, M.P. & Greer, J.M. (2007) Immunology of multiple sclerosis. Current Allergy and Asthma Reports, 7, 285.
39. Polman, C.H., Reingold, S.C., Edan, G., Filippi, M., Hartung, H.P., Kappos, L. et al. (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Annals of Neurology, 58, 840.
40. Ramagopalan, S.V. & Dyment, D.A. (2011) What is next for the genetics of multiple sclerosis? Autoimmune Diseases, 2011, 519450.
41. Rasmussen, H.B., Kelly, M.A., Francis, D.A. & Clausen, J. (2001) CTLA4 in multiple sclerosis. Lack of genetic association in a European Caucasian population but evidence of interaction with HLA-DR2 among Shanghai Chinese. Journal of the Neurological Sciences, 184, 143.
42. Roxburgh, R.H., Sawcer, S., Maranian, M., Seaman, S., Hensiek, A., Yeo, T., Deans, J. & Compston, A. (2006) No evidence of a significant role for CTLA-4 in multiple sclerosis. Journal of Neuroimmunology, 171, 193.
43. Suppiah, V., Alloza, I., Heggarty, S., Goris, A., Dubois, B., Carton, H. & Vandenbroeck, K. (2005) The CTLA4 +49 A/G*G-CT60*G haplotype is associated with susceptibility to multiple sclerosis in Flanders. Journal of Neuroimmunology, 164, 148.
44. Takahashi, M. & Kimura, A. (2010) HLA and CTLA4 polymorphisms may confer a synergistic risk in the susceptibility to Graves' disease. Journal of Human Genetics, 55, 323.
45. Teft, W.A., Kirchhof, M.G. & Madrenas, J. (2006) A molecular perspective of CTLA-4 function. Annual Review of Immunology, 24, 65.
46. Teutsch, S.M., Booth, D.R., Bennetts, B.H., Heard, R.N. & Stewart, G.J. (2004) Association of common T cell activation gene polymorphisms with multiple sclerosis in Australian patients. Journal of Neuroimmunology, 148, 218.
47. van Veen, T., Crusius, J.B., van Winsen, L., Xia, B., Barkhof, F., Salvador Pena, A., Polman, C.H. & Uitdehaag, B.M. (2003) CTLA-4 and CD28 gene polymorphisms in susceptibility, clinical course and progression of multiple sclerosis. Journal of Neuroimmunology, 140, 188.
48. Wray, B.N., Stankovich, J., Whittock, L., Dwyer, T., Ponsonby, A.L., van der Mei, I.A., Taylor, B., Dickinson, J., Foote, S. & McMorran, B.J. (2008) CTLA-4 and multiple sclerosis: the A49G single nucleotide polymorphism shows no association with multiple sclerosis in a Southern Australian population. Journal of Neuroimmunology, 196, 139.
49. Yousefipour, G., Erfani, N., Momtahan, M., Moghaddasi, H. & Ghaderi, A. (2009) CTLA4 exon 1 and promoter polymorphisms in patients with multiple sclerosis. Acta Neurologica Scandinavica, 120, 424.